-
Views
-
Cite
Cite
Roger Bedimo, Ray Y. Chen, Neil A. Accortt, James L. Raper, Carol Linn, Jeroan J. Allison, John Dubay, Michael S. Saag, Craig J. Hoesley, Trends in AIDS-Defining and Non—AIDS-Defining Malignancies among HIV-Infected Patients: 1989–2002, Clinical Infectious Diseases, Volume 39, Issue 9, 1 November 2004, Pages 1380–1384, https://doi.org/10.1086/424883
- Share Icon Share
Abstract
In a comparison of rates of acquired immunodeficiency syndrome (AIDS)–defining malignancies (ADMs) for 1989–1996 versus 1997–2002, we found a decrease in ADMs (rate ratio, 0.31; P < .0001) and a significant increase in non—AIDS-defining malignancies (non-ADMs; rate ratio, 10.87; P < .0002). The mean CD4 cell count was lower among patients with ADMs than among those with non-ADMs. A longer duration of survival during highly active antiretroviral therapy might explain the increasing incidence of non-ADMs.